Review





Similar Products

87
Thermo Fisher gene exp ramp3 hs00389131 m1
Gene Exp Ramp3 Hs00389131 M1, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 87/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ramp3/pmc12623973-499-30--1?v=Thermo+Fisher
Average 87 stars, based on 1 article reviews
gene exp ramp3 hs00389131 m1 - by Bioz Stars, 2026-08
87/100 stars
  Buy from Supplier

93
Santa Cruz Biotechnology ramp3
Ramp3, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ramp3/pm40602647-50-4-21?v=Santa+Cruz+Biotechnology
Average 93 stars, based on 1 article reviews
ramp3 - by Bioz Stars, 2026-08
93/100 stars
  Buy from Supplier

93
Santa Cruz Biotechnology anti ramp3 monoclonal antibody
Anti Ramp3 Monoclonal Antibody, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ramp3/pm40527324-444-36-39?v=Santa+Cruz+Biotechnology
Average 93 stars, based on 1 article reviews
anti ramp3 monoclonal antibody - by Bioz Stars, 2026-08
93/100 stars
  Buy from Supplier

85
Santa Cruz Biotechnology sirnas
Figure 3. Identification of EdTx-induced, cytotoxicity-related genes. Total RNA was isolated from primary hepatocytes treated with PBS or EdTx (4 µg/mL) for 6 h, and the samples were subjected to microarray analysis using the GeneChips Mouse Transcriptome Assay 1.0. Some genes (218) were found to have significant expression changes in primary hepatocytes exposed to EdTx treatment com- pared with PBS-treated cells. The Partek Genomics Suite was used to analyze the signaling pathways associated with these differentially expressed genes. (A) The pathways with enrichment score > 2 and p-value < 0.05 are shown. The numbers at the top of each column show the number of genes that have expression changes in each pathway. (B) The 35 significantly changed genes and sequencing expression fold changes. * p < 0.05, ** p < 0.01 vs. PBS. (C) The results of a protein–protein network analysis among the 35 genes are shown. Nine genes that are involved in glycogen metabolism, cAMP production, and cell apoptosis are marked with red circles and were further investigated in the following experiments. (D) These potential EdTx-induced cytotoxicity-related genes were knocked down individually or in combination in primary hepatocytes using the corresponding <t>siRNAs.</t> si-CMG2 was used as a positive control, and si-GFP and si-(no gene) were used as negative controls. Primary hepatocytes deficient in these genes were treated with PBS or EdTx (4 µg/mL) for 6 h. The intracellular concentration of cAMP was determined using ELISA. * p < 0.05, ** p < 0.01 vs. si-GFP (n = 3). <t>4mix,</t> <t>Ramp3</t> + Rgs1 + Pck1 + G6pc; 5mix, Hcar2 + Fosl2 + Fos + Cxcl2 + Cxcl3.
Sirnas, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 85/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ramp3/pm39998071-345-0-29?v=Santa+Cruz+Biotechnology
Average 85 stars, based on 1 article reviews
sirnas - by Bioz Stars, 2026-08
85/100 stars
  Buy from Supplier

85
Santa Cruz Biotechnology murine ramp3
Figure 3. Identification of EdTx-induced, cytotoxicity-related genes. Total RNA was isolated from primary hepatocytes treated with PBS or EdTx (4 µg/mL) for 6 h, and the samples were subjected to microarray analysis using the GeneChips Mouse Transcriptome Assay 1.0. Some genes (218) were found to have significant expression changes in primary hepatocytes exposed to EdTx treatment com- pared with PBS-treated cells. The Partek Genomics Suite was used to analyze the signaling pathways associated with these differentially expressed genes. (A) The pathways with enrichment score > 2 and p-value < 0.05 are shown. The numbers at the top of each column show the number of genes that have expression changes in each pathway. (B) The 35 significantly changed genes and sequencing expression fold changes. * p < 0.05, ** p < 0.01 vs. PBS. (C) The results of a protein–protein network analysis among the 35 genes are shown. Nine genes that are involved in glycogen metabolism, cAMP production, and cell apoptosis are marked with red circles and were further investigated in the following experiments. (D) These potential EdTx-induced cytotoxicity-related genes were knocked down individually or in combination in primary hepatocytes using the corresponding siRNAs. si-CMG2 was used as a positive control, and si-GFP and si-(no gene) were used as negative controls. Primary hepatocytes deficient in these genes were treated with PBS or EdTx (4 µg/mL) for 6 h. The intracellular concentration of cAMP was determined using ELISA. * p < 0.05, ** p < 0.01 vs. si-GFP (n = 3). 4mix, <t>Ramp3</t> + Rgs1 + Pck1 + G6pc; 5mix, Hcar2 + Fosl2 + Fos + Cxcl2 + Cxcl3.
Murine Ramp3, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 85/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ramp3/pm39998071-345-3-29?v=Santa+Cruz+Biotechnology
Average 85 stars, based on 1 article reviews
murine ramp3 - by Bioz Stars, 2026-08
85/100 stars
  Buy from Supplier

86
Thermo Fisher gene exp ramp3 rn00571815 m1
Figure 3. Identification of EdTx-induced, cytotoxicity-related genes. Total RNA was isolated from primary hepatocytes treated with PBS or EdTx (4 µg/mL) for 6 h, and the samples were subjected to microarray analysis using the GeneChips Mouse Transcriptome Assay 1.0. Some genes (218) were found to have significant expression changes in primary hepatocytes exposed to EdTx treatment com- pared with PBS-treated cells. The Partek Genomics Suite was used to analyze the signaling pathways associated with these differentially expressed genes. (A) The pathways with enrichment score > 2 and p-value < 0.05 are shown. The numbers at the top of each column show the number of genes that have expression changes in each pathway. (B) The 35 significantly changed genes and sequencing expression fold changes. * p < 0.05, ** p < 0.01 vs. PBS. (C) The results of a protein–protein network analysis among the 35 genes are shown. Nine genes that are involved in glycogen metabolism, cAMP production, and cell apoptosis are marked with red circles and were further investigated in the following experiments. (D) These potential EdTx-induced cytotoxicity-related genes were knocked down individually or in combination in primary hepatocytes using the corresponding siRNAs. si-CMG2 was used as a positive control, and si-GFP and si-(no gene) were used as negative controls. Primary hepatocytes deficient in these genes were treated with PBS or EdTx (4 µg/mL) for 6 h. The intracellular concentration of cAMP was determined using ELISA. * p < 0.05, ** p < 0.01 vs. si-GFP (n = 3). 4mix, <t>Ramp3</t> + Rgs1 + Pck1 + G6pc; 5mix, Hcar2 + Fosl2 + Fos + Cxcl2 + Cxcl3.
Gene Exp Ramp3 Rn00571815 M1, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ramp3/pmc11928841-11-6-3?v=Thermo+Fisher
Average 86 stars, based on 1 article reviews
gene exp ramp3 rn00571815 m1 - by Bioz Stars, 2026-08
86/100 stars
  Buy from Supplier

Image Search Results


Figure 3. Identification of EdTx-induced, cytotoxicity-related genes. Total RNA was isolated from primary hepatocytes treated with PBS or EdTx (4 µg/mL) for 6 h, and the samples were subjected to microarray analysis using the GeneChips Mouse Transcriptome Assay 1.0. Some genes (218) were found to have significant expression changes in primary hepatocytes exposed to EdTx treatment com- pared with PBS-treated cells. The Partek Genomics Suite was used to analyze the signaling pathways associated with these differentially expressed genes. (A) The pathways with enrichment score > 2 and p-value < 0.05 are shown. The numbers at the top of each column show the number of genes that have expression changes in each pathway. (B) The 35 significantly changed genes and sequencing expression fold changes. * p < 0.05, ** p < 0.01 vs. PBS. (C) The results of a protein–protein network analysis among the 35 genes are shown. Nine genes that are involved in glycogen metabolism, cAMP production, and cell apoptosis are marked with red circles and were further investigated in the following experiments. (D) These potential EdTx-induced cytotoxicity-related genes were knocked down individually or in combination in primary hepatocytes using the corresponding siRNAs. si-CMG2 was used as a positive control, and si-GFP and si-(no gene) were used as negative controls. Primary hepatocytes deficient in these genes were treated with PBS or EdTx (4 µg/mL) for 6 h. The intracellular concentration of cAMP was determined using ELISA. * p < 0.05, ** p < 0.01 vs. si-GFP (n = 3). 4mix, Ramp3 + Rgs1 + Pck1 + G6pc; 5mix, Hcar2 + Fosl2 + Fos + Cxcl2 + Cxcl3.

Journal: Toxins

Article Title: Identification of Potential Therapeutic Targets Against Anthrax-Toxin-Induced Liver and Heart Damage.

doi: 10.3390/toxins17020054

Figure Lengend Snippet: Figure 3. Identification of EdTx-induced, cytotoxicity-related genes. Total RNA was isolated from primary hepatocytes treated with PBS or EdTx (4 µg/mL) for 6 h, and the samples were subjected to microarray analysis using the GeneChips Mouse Transcriptome Assay 1.0. Some genes (218) were found to have significant expression changes in primary hepatocytes exposed to EdTx treatment com- pared with PBS-treated cells. The Partek Genomics Suite was used to analyze the signaling pathways associated with these differentially expressed genes. (A) The pathways with enrichment score > 2 and p-value < 0.05 are shown. The numbers at the top of each column show the number of genes that have expression changes in each pathway. (B) The 35 significantly changed genes and sequencing expression fold changes. * p < 0.05, ** p < 0.01 vs. PBS. (C) The results of a protein–protein network analysis among the 35 genes are shown. Nine genes that are involved in glycogen metabolism, cAMP production, and cell apoptosis are marked with red circles and were further investigated in the following experiments. (D) These potential EdTx-induced cytotoxicity-related genes were knocked down individually or in combination in primary hepatocytes using the corresponding siRNAs. si-CMG2 was used as a positive control, and si-GFP and si-(no gene) were used as negative controls. Primary hepatocytes deficient in these genes were treated with PBS or EdTx (4 µg/mL) for 6 h. The intracellular concentration of cAMP was determined using ELISA. * p < 0.05, ** p < 0.01 vs. si-GFP (n = 3). 4mix, Ramp3 + Rgs1 + Pck1 + G6pc; 5mix, Hcar2 + Fosl2 + Fos + Cxcl2 + Cxcl3.

Article Snippet: siRNAs targeting the murine Ramp3 (si-Ramp3), Rgs1 (si-Rgs1), Pck1 (si-Pck1), G6pc (si-G6pc), Hcar2 (si-Hcar2), Fosl2 (si-Fosl2), Fos (si-Fos), Cxcl2 (si-Cxcl2), Cxcl3 (si-Cxcl3), and Cmg2 (si-CMG2) genes were provided by Santa Cruz Biotechnology.

Techniques: Isolation, Microarray, Expressing, Protein-Protein interactions, Sequencing, Positive Control, Concentration Assay, Enzyme-linked Immunosorbent Assay

Figure 3. Identification of EdTx-induced, cytotoxicity-related genes. Total RNA was isolated from primary hepatocytes treated with PBS or EdTx (4 µg/mL) for 6 h, and the samples were subjected to microarray analysis using the GeneChips Mouse Transcriptome Assay 1.0. Some genes (218) were found to have significant expression changes in primary hepatocytes exposed to EdTx treatment com- pared with PBS-treated cells. The Partek Genomics Suite was used to analyze the signaling pathways associated with these differentially expressed genes. (A) The pathways with enrichment score > 2 and p-value < 0.05 are shown. The numbers at the top of each column show the number of genes that have expression changes in each pathway. (B) The 35 significantly changed genes and sequencing expression fold changes. * p < 0.05, ** p < 0.01 vs. PBS. (C) The results of a protein–protein network analysis among the 35 genes are shown. Nine genes that are involved in glycogen metabolism, cAMP production, and cell apoptosis are marked with red circles and were further investigated in the following experiments. (D) These potential EdTx-induced cytotoxicity-related genes were knocked down individually or in combination in primary hepatocytes using the corresponding siRNAs. si-CMG2 was used as a positive control, and si-GFP and si-(no gene) were used as negative controls. Primary hepatocytes deficient in these genes were treated with PBS or EdTx (4 µg/mL) for 6 h. The intracellular concentration of cAMP was determined using ELISA. * p < 0.05, ** p < 0.01 vs. si-GFP (n = 3). 4mix, Ramp3 + Rgs1 + Pck1 + G6pc; 5mix, Hcar2 + Fosl2 + Fos + Cxcl2 + Cxcl3.

Journal: Toxins

Article Title: Identification of Potential Therapeutic Targets Against Anthrax-Toxin-Induced Liver and Heart Damage.

doi: 10.3390/toxins17020054

Figure Lengend Snippet: Figure 3. Identification of EdTx-induced, cytotoxicity-related genes. Total RNA was isolated from primary hepatocytes treated with PBS or EdTx (4 µg/mL) for 6 h, and the samples were subjected to microarray analysis using the GeneChips Mouse Transcriptome Assay 1.0. Some genes (218) were found to have significant expression changes in primary hepatocytes exposed to EdTx treatment com- pared with PBS-treated cells. The Partek Genomics Suite was used to analyze the signaling pathways associated with these differentially expressed genes. (A) The pathways with enrichment score > 2 and p-value < 0.05 are shown. The numbers at the top of each column show the number of genes that have expression changes in each pathway. (B) The 35 significantly changed genes and sequencing expression fold changes. * p < 0.05, ** p < 0.01 vs. PBS. (C) The results of a protein–protein network analysis among the 35 genes are shown. Nine genes that are involved in glycogen metabolism, cAMP production, and cell apoptosis are marked with red circles and were further investigated in the following experiments. (D) These potential EdTx-induced cytotoxicity-related genes were knocked down individually or in combination in primary hepatocytes using the corresponding siRNAs. si-CMG2 was used as a positive control, and si-GFP and si-(no gene) were used as negative controls. Primary hepatocytes deficient in these genes were treated with PBS or EdTx (4 µg/mL) for 6 h. The intracellular concentration of cAMP was determined using ELISA. * p < 0.05, ** p < 0.01 vs. si-GFP (n = 3). 4mix, Ramp3 + Rgs1 + Pck1 + G6pc; 5mix, Hcar2 + Fosl2 + Fos + Cxcl2 + Cxcl3.

Article Snippet: siRNAs targeting the murine Ramp3 (si-Ramp3), Rgs1 (si-Rgs1), Pck1 (si-Pck1), G6pc (si-G6pc), Hcar2 (si-Hcar2), Fosl2 (si-Fosl2), Fos (si-Fos), Cxcl2 (si-Cxcl2), Cxcl3 (si-Cxcl3), and Cmg2 (si-CMG2) genes were provided by Santa Cruz Biotechnology.

Techniques: Isolation, Microarray, Expressing, Protein-Protein interactions, Sequencing, Positive Control, Concentration Assay, Enzyme-linked Immunosorbent Assay